John W. McBroom

718 total citations
18 papers, 546 citations indexed

About

John W. McBroom is a scholar working on Surgery, Epidemiology and Obstetrics and Gynecology. According to data from OpenAlex, John W. McBroom has authored 18 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Epidemiology and 5 papers in Obstetrics and Gynecology. Recurrent topics in John W. McBroom's work include Cervical Cancer and HPV Research (5 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Ovarian cancer diagnosis and treatment (3 papers). John W. McBroom is often cited by papers focused on Cervical Cancer and HPV Research (5 papers), Endometrial and Cervical Cancer Treatments (5 papers) and Ovarian cancer diagnosis and treatment (3 papers). John W. McBroom collaborates with scholars based in United States. John W. McBroom's co-authors include Thomas C. Krivak, G. Scott Rose, Ahmed Mohyeldin, Géza Ács, Péter Ács, Suzhen Liu, Ajay Verma, Cindy McGrath, Huasheng Lu and Paul J. Zhang and has published in prestigious journals such as Journal of Clinical Oncology, American Journal Of Pathology and Obstetrics and Gynecology.

In The Last Decade

John W. McBroom

17 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John W. McBroom United States 13 146 133 127 106 96 18 546
J. Mazurka Canada 10 25 0.2× 120 0.9× 170 1.3× 167 1.6× 177 1.8× 15 488
Salvador Grancha Spain 14 331 2.3× 17 0.1× 137 1.1× 73 0.7× 47 0.5× 28 646
Çiğdem Vural Türkiye 13 9 0.1× 63 0.5× 48 0.4× 86 0.8× 50 0.5× 57 401
Lucia Cottone United Kingdom 12 12 0.1× 115 0.9× 305 2.4× 170 1.6× 408 4.3× 23 952
Hiroyuki Hiraki Japan 10 21 0.1× 97 0.7× 21 0.2× 109 1.0× 14 0.1× 15 372
Jim Biagi Canada 10 9 0.1× 158 1.2× 252 2.0× 238 2.2× 275 2.9× 17 648
Rahul Hejmadi United Kingdom 12 19 0.1× 136 1.0× 19 0.1× 78 0.7× 24 0.3× 34 384
Theresa Kapral Austria 7 60 0.4× 99 0.7× 15 0.1× 193 1.8× 10 0.1× 8 405
Eunyoung Lee South Korea 11 96 0.7× 121 0.9× 7 0.1× 131 1.2× 16 0.2× 30 458
Heung Yeol Kim South Korea 14 6 0.0× 182 1.4× 199 1.6× 93 0.9× 175 1.8× 38 532

Countries citing papers authored by John W. McBroom

Since Specialization
Citations

This map shows the geographic impact of John W. McBroom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. McBroom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. McBroom more than expected).

Fields of papers citing papers by John W. McBroom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. McBroom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. McBroom. The network helps show where John W. McBroom may publish in the future.

Co-authorship network of co-authors of John W. McBroom

This figure shows the co-authorship network connecting the top 25 collaborators of John W. McBroom. A scholar is included among the top collaborators of John W. McBroom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John W. McBroom. John W. McBroom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Darcy, Kathleen M., William E. Brady, John W. McBroom, et al.. (2008). Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers. Gynecologic Oncology. 111(3). 487–495. 36 indexed citations
2.
Farley, John, John W. McBroom, & Christopher M. Zahn. (2005). Current Techniques for the Evaluation of Abnormal Cervical Cytology. Clinical Obstetrics & Gynecology. 48(1). 133–146. 3 indexed citations
3.
McBroom, John W., Géza Ács, G Rose, et al.. (2005). Erythropoeitin receptor function and expression in epithelial ovarian carcinoma. Gynecologic Oncology. 99(3). 571–577. 29 indexed citations
4.
Farley, John, et al.. (2005). A randomized double-blind phase II evaluation of the cyclooxygenase-2 protein inhibitor celecoxib in treating severe dysplasia of the cervix. Journal of Clinical Oncology. 23(16_suppl). 5106–5106. 1 indexed citations
5.
Dainty, Louis A., et al.. (2005). Novel techniques to improve split-thickness skin graft viability during vulvo-vaginal reconstruction. Gynecologic Oncology. 97(3). 949–952. 18 indexed citations
6.
McBroom, John W., et al.. (2004). Vaginal metastasis and thrombocytopenia from renal cell carcinoma. Gynecologic Oncology. 92(3). 970–973. 26 indexed citations
7.
Booth, Caroline, Chris Zahn, John W. McBroom, & G. Larry Maxwell. (2004). Retroperitoneal müllerian carcinosarcoma associated with endometriosis: a case report. Gynecologic Oncology. 93(2). 546–549. 17 indexed citations
8.
Ács, Géza, Paul J. Zhang, Cindy McGrath, et al.. (2003). Hypoxia-Inducible Erythropoietin Signaling in Squamous Dysplasia and Squamous Cell Carcinoma of the Uterine Cervix and Its Potential Role in Cervical Carcinogenesis and Tumor Progression. American Journal Of Pathology. 162(6). 1789–1806. 170 indexed citations
9.
Winter, William E., John W. McBroom, Jay W. Carlson, G. Scott Rose, & John C. Elkas. (2003). The utility of gastrojejunostomy in secondary cytoreduction and palliation of proximal intestinal obstruction in recurrent ovarian cancer. Gynecologic Oncology. 91(1). 261–264. 1 indexed citations
10.
Winter, William E., Paul R. Kucera, William H. Rodgers, et al.. (2002). Surgical Staging in Patients With Ovarian Tumors of Low Malignant Potential. Obstetrics and Gynecology. 100(4). 671–676. 17 indexed citations
11.
Krivak, Thomas C., John W. McBroom, Jeffrey D. Seidman, et al.. (2001). Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.. PubMed. 61(11). 4382–5. 17 indexed citations
12.
Krivak, Thomas C., G. Scott Rose, John W. McBroom, et al.. (2001). Cervical Adenocarcinoma in Situ: A Systematic Review of Therapeutic Options and Predictors of Persistent or Recurrent Disease. Obstetrical & Gynecological Survey. 56(9). 567–575. 32 indexed citations
13.
Krivak, Thomas C., et al.. (2001). Large Cell Neuroendocrine Cervical Carcinoma: A Report of Two Cases and Review of the Literature. Gynecologic Oncology. 82(1). 187–191. 39 indexed citations
14.
Krivak, Thomas C., et al.. (2001). Uterine Adenosarcoma with Sarcomatous Overgrowth versus Uterine Carcinosarcoma: Comparison of Treatment and Survival. Gynecologic Oncology. 83(1). 89–94. 67 indexed citations
15.
McBroom, John W., et al.. (2000). Primary Appendiceal Malignancy Mimicking Advanced Stage Ovarian Carcinoma: A Case Series. Gynecologic Oncology. 78(3). 388–390. 15 indexed citations
16.
Krivak, Thomas C., et al.. (2000). Cervical adenocarcinoma‐in‐situ: A meta‐analysis of therapeutic options and predictors of persistent or recurrent disease. International Journal of Gynecology & Obstetrics. 70(S2).
17.
Williams, David R., Charles S. Dietrich, & John W. McBroom. (2000). Endocervical Curettage When Colposcopic Examination Is Satisfactory and Normal. Obstetrics and Gynecology. 95(6, Part 1). 801–803. 5 indexed citations
18.
McBroom, John W., et al.. (1977). Effects of taurine on heart calcium in the cardiomyopathic hamster. Journal of Molecular and Cellular Cardiology. 9(10). 853–858. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026